Wen-An Pan

Senior Scientist, Drug Discovery and Cancer Biology at Solve Therapeutics, Inc.

Wen-An Pan has extensive experience in scientific research and drug discovery. They began their career as a Postdoctoral Fellow at Sanford Burnham Prebys Medical Discovery Institute in 2015, where they worked until February 2016. Following this, they joined UC San Diego as a Postdoctoral Fellow and worked there for four and a half years, until September 2020. In October 2020, they joined Lassogen, Inc. as a Scientist II, specializing in Biology, and worked there until February 2021. They then worked at Thermo Fisher Scientific as a Scientist III, focusing on Cell Biology, from March 2021 to May 2021. In June 2021, they joined Zentalis Pharmaceuticals as a Senior Scientist in Discovery Biology and worked there until March 2023. Currently, Wen-An Pan holds the position of Senior Scientist in Drug Discovery and Cancer Biology at Solve Therapeutics, Inc., starting in April 2023.

Wen-An Pan has a strong educational background in the field of Biochemistry. Wen-An obtained their Bachelor's degree in Biology, General from National Sun Yat-Sen University between the years 2000 and 2004. Wen-An then pursued further studies, earning a Master's degree in Biochemistry and Molecular Biology from National Cheng Kung University from 2004 to 2006. Continuing their academic journey, they obtained a Doctor of Philosophy (Ph.D.) in Biochemistry from National Taiwan University, where they studied from 2008 to 2015.

Location

San Diego, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Solve Therapeutics, Inc.

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics. The company was founded in 2021 and is headquartered in Belmont, California.


Employees

11-50

Links